These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 15457470)
1. Efficacy of modified recombinant type II collagen in modulating autoimmune arthritis. Myers LK; Tang B; Brand DD; Rosloniec EF; Stuart JM; Kang AH Arthritis Rheum; 2004 Sep; 50(9):3004-11. PubMed ID: 15457470 [TBL] [Abstract][Full Text] [Related]
2. Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice. Myers LK; Sakurai Y; Tang B; He X; Rosloniec EF; Stuart JM; Kang AH Arthritis Rheum; 2002 Dec; 46(12):3369-77. PubMed ID: 12483744 [TBL] [Abstract][Full Text] [Related]
3. Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response. Mauri C; Feldmann M; Williams RO Arthritis Rheum; 2003 Mar; 48(3):839-45. PubMed ID: 12632440 [TBL] [Abstract][Full Text] [Related]
4. T cell receptors recognizing type II collagen in HLA-DR-transgenic mice characterized by highly restricted V beta usage. He X; Rosloniec EF; Myers LK; McColgan WL; Gumanovskaya M; Kang AH; Stuart JM Arthritis Rheum; 2004 Jun; 50(6):1996-2004. PubMed ID: 15188377 [TBL] [Abstract][Full Text] [Related]
5. Characterization of a peptide analog of a determinant of type II collagen that suppresses collagen-induced arthritis. Myers LK; Tang B; Rosloniec EF; Stuart JM; Chiang TM; Kang AH J Immunol; 1998 Oct; 161(7):3589-95. PubMed ID: 9759881 [TBL] [Abstract][Full Text] [Related]
6. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis. Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846 [TBL] [Abstract][Full Text] [Related]
7. The impact of glycosylation on HLA-DR1-restricted T cell recognition of type II collagen in a mouse model. von Delwig A; Altmann DM; Isaacs JD; Harding CV; Holmdahl R; McKie N; Robinson JH Arthritis Rheum; 2006 Feb; 54(2):482-91. PubMed ID: 16447222 [TBL] [Abstract][Full Text] [Related]
8. Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice. Sakurai Y; Brand DD; Tang B; Rosloniec EF; Stuart JM; Kang AH; Myers LK Arthritis Res Ther; 2006; 8(5):R150. PubMed ID: 16982003 [TBL] [Abstract][Full Text] [Related]
9. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen. Rosloniec EF; Brand DD; Myers LK; Esaki Y; Whittington KB; Zaller DM; Woods A; Stuart JM; Kang AH J Immunol; 1998 Mar; 160(6):2573-8. PubMed ID: 9510154 [TBL] [Abstract][Full Text] [Related]
10. The role of IL-4 in regulation of murine collagen-induced arthritis. Myers LK; Tang B; Stuart JM; Kang AH Clin Immunol; 2002 Feb; 102(2):185-91. PubMed ID: 11846461 [TBL] [Abstract][Full Text] [Related]
11. Breaking T cell tolerance against self type II collagen in HLA-DR4-transgenic mice and development of autoimmune arthritis. Batsalova T; Dzhambazov B; Merky P; Bäcklund A; Bäcklund J Arthritis Rheum; 2010 Jul; 62(7):1911-20. PubMed ID: 20309862 [TBL] [Abstract][Full Text] [Related]
12. Reduction of the incidence and severity of collagen-induced arthritis by constitutive Nur77 expression in the T cell lineage. De Silva S; Han S; Zhang X; Huston DP; Winoto A; Zheng B Arthritis Rheum; 2005 Jan; 52(1):333-8. PubMed ID: 15641076 [TBL] [Abstract][Full Text] [Related]
13. An autoantigen-specific, highly restricted T cell repertoire infiltrates the arthritic joints of mice in an HLA-DR1 humanized mouse model of autoimmune arthritis. Qian Z; Latham KA; Whittington KB; Miller DC; Brand DD; Rosloniec EF J Immunol; 2010 Jul; 185(1):110-8. PubMed ID: 20511555 [TBL] [Abstract][Full Text] [Related]
14. Effect of sinomenine on collagen-induced arthritis in mice. Feng H; Yamaki K; Takano H; Inoue K; Yanagisawa R; Yoshino S Autoimmunity; 2007 Nov; 40(7):532-9. PubMed ID: 17966044 [TBL] [Abstract][Full Text] [Related]
15. Immunopathogenesis of collagen arthritis. Brand DD; Kang AH; Rosloniec EF Springer Semin Immunopathol; 2003 Aug; 25(1):3-18. PubMed ID: 12904888 [TBL] [Abstract][Full Text] [Related]
16. Glycosylation of type II collagen is of major importance for T cell tolerance and pathology in collagen-induced arthritis. Bäcklund J; Treschow A; Bockermann R; Holm B; Holm L; Issazadeh-Navikas S; Kihlberg J; Holmdahl R Eur J Immunol; 2002 Dec; 32(12):3776-84. PubMed ID: 12516572 [TBL] [Abstract][Full Text] [Related]
17. Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background. Zhou F; He X; Iwakura Y; Horai R; Stuart JM Arthritis Rheum; 2005 Dec; 52(12):3731-8. PubMed ID: 16320323 [TBL] [Abstract][Full Text] [Related]
18. Collagen-induced arthritis mediated by HLA-DR1 (*0101) and HLA-DR4 (*0401). Rosloniec EF; Whittington KB; He X; Stuart JM; Kang AH Am J Med Sci; 2004 Apr; 327(4):169-79. PubMed ID: 15084912 [TBL] [Abstract][Full Text] [Related]
19. Relevance of posttranslational modifications for the arthritogenicity of type II collagen. Myers LK; Myllyharju J; Nokelainen M; Brand DD; Cremer MA; Stuart JM; Bodo M; Kivirikko KI; Kang AH J Immunol; 2004 Mar; 172(5):2970-5. PubMed ID: 14978100 [TBL] [Abstract][Full Text] [Related]
20. Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells. Nandakumar KS; Bäcklund J; Vestberg M; Holmdahl R Arthritis Res Ther; 2004; 6(6):R544-50. PubMed ID: 15535832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]